Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age and one of the important causes of infertility due to a lack of ovulation. OBJECTIVE: Given the consideration of herbal medicines in the treatment of this condition, this systematic review was conducted to investigate the effect of herbal compounds on the treatment of PCOS. METHOD: In this systematic review, all original articles on human subjects investigating the effect of medicinal plants on PCOS that were published in Farsi or English were searched in Persian (Magiran and Scientific Information Database [SID]), and English (PubMed, Scopus, Google Scholar, and Web of Science) databases until August 2025. Exclusion criteria included duplicated publications and the unavailability of full-text articles. Search keywords included polycystic ovary syndrome, medicinal plants, systematic review, Traditional medicine, clinical trial, case-control study, female infertility, and women in Persian and their English equivalents. Of the primary 182 articles, the full text of 36 articles was screened based on the inclusion and exclusion criteria. Quality assessment, including risk of bias, was performed using the Jadad checklist. Finally, ten related articles were included in the study. RESULTS: Out of the 10 included studies (seven conducted in Iran and one each in China, the United States, and Oman, with a total of 548 participants) were included in the review. According to…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 548 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.